{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Robert", "organization": "", "rank": 1, "lastname": "CYRAN"}], "original": "By ROBERT CYRAN"}, "news_desk": "Business", "slideshow_credits": null, "abstract": null, "multimedia": [], "headline": {"content_kicker": "Breakingviews", "main": "Change Is in the Air for Pharmaceutical Mergers"}, "print_page": null, "keywords": [{"value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Allergan Inc", "is_major": "N", "rank": "2", "name": "organizations"}, {"value": "Zoetis Inc", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Ackman, William A", "is_major": "N", "rank": "4", "name": "persons"}, {"value": "Pfizer Inc", "is_major": "N", "rank": "5", "name": "organizations"}], "snippet": "The recent actions of Zoetis and Allergan suggest a more subdued approach to deals.", "source": "The New York Times", "lead_paragraph": "The recent actions of Zoetis and Allergan suggest a more subdued approach to deals.", "word_count": "386", "pub_date": "2016-05-11T00:00:00Z", "subsection_name": "DealBook", "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/05/11/business/dealbook/change-is-in-the-air-for-pharmaceutical-mergers.html", "_id": "5732686338f0d83b1f371443"}